HOME >> BIOLOGY >> NEWS
Conservative forces hampering progress in sexual and reproductive health

The increasing influence of conservative political, religious, and cultural forces around the world threatens to undermine progress in sexual and reproductive health (SRH), according to the first article in The Lancet's Sexual and Reproductive Health Online/Series published today (Wednesday November 1, 2006).

In the paper, Anna Glasier (University of Edinburgh, UK), Metin Gulmezoglu (World Health Organization) and colleagues highlight the enormous burden of sexual and reproductive ill-health. Every year, 340 million new patients acquire gonorrhoea, syphilis, chlamydia, or trichomonas, more than 120 million couples have an unmet need for contraception, 80 million women have unintended pregnancies, and an estimated 19 million women undergo unsafe abortions; 70 000 of them die as a result.

Cheap, effective measures are available to prevent unintended pregnancy, provide safe abortions, help women safely through pregnancy and childbirth, and prevent and treat sexually transmitted infections. But opposition from conservative groups is hampering the provision of these life-saving strategies in almost all countries. The authors say that overcoming this opposition is the greatest challenge to sexual-health promotion globally and the best example of the detrimental intrusion of politics into public health.

In a Comment to introduce the Online/Series, Richard Horton, Editor of The Lancet, states: "Sex, abortion, and birth control, and sexually transmitted infection (including HIV/AIDS) are taboo subjects for many countries, cultures, and religions. For example, for largely political reasons, the USA has blocked programmes to save the lives of women from unwanted pregnancy. For doctrinal reasons, the Catholic Church has rejected simple and effective techniques that would have substantial impact not only on fertility rates but also on rates of human development."

In an accompanying Comment, Gareth Thomas (UK Department for International
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
31-Oct-2006


Page: 1 2

Related biology news :

1. Wild weather forces farmers to adapt
2. Sleep enforces the temporal sequence in memory
3. Arizona State University and Mayo Clinic join forces to develop cancer vaccine
4. Joining forces
5. Feinstein Institute and Cold Spring Harbor Lab join forces, seek manic depression genes
6. New genetic analysis forces re-draw of insect family tree
7. Genetic research at Childrens Hospital of Pittsburgh reinforces theory of evolution
8. Texas A&M system agencies join forces to hasten bioenergy revolution
9. Salk and Stanford teams join forces to reveal two paths of neurodegeneration
10. Evolutionary forces explain why women live longer than men
11. 16-Year follow-up study reinforces Betaseron long-term efficacy, safety and tolerability in MS

Post Your Comments:
(Date:2/9/2015)... , Feb. 9, 2015  Lintec of America ... methods for carbon nanotube (CNT) macrostructures, including sheets, yarns ... Dallas (UTD). Leveraging the vast industrial resources ... Tokyo, Japan , Lintec of America is forming ... Richardson, TX , focusing on scaling up the ...
(Date:2/5/2015)... 2015   Marvin Test Solutions , ... test solutions for military, aerospace, and manufacturing ... TS-323 GENASYS Test Platform to ... is a high-performance PXI-based system designed to ... require performance functional testing. GENASYS features a ...
(Date:2/5/2015)... MOUNTAIN VIEW, Calif. , Feb. 3, 2015 ... screen printer technology, demand from industries such as ... the global market for surface mount technology (SMT) ... manual equipment to automatic control will push the ... glue dispensers will remain steady as glue dispensers ...
Breaking Biology News(10 mins):Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 2End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 3
(Date:2/26/2015)... Feb. 26, 2015 S&P Capital IQ (MHFI) ... Report coverage on MabVax Therapeutics Holdings Inc . ... clinical stage biotechnology company focused on the development of ... in the treatment of cancer. MabVax has discovered a ... protective immune responses generated by patients who have been ...
(Date:2/26/2015)... TORONTO , Feb. 26, 2015 /PRNewswire/ - SQI ... SQIDF), a life sciences company that develops and commercializes ... reported its financial and operational results for the fiscal ... this press release are in Canadian dollars (CAD), unless ... Company continued to win new business from our existing ...
(Date:2/26/2015)... MENLO PARK, Calif. , Feb. 26, 2015 /PRNewswire/ ... has released the latest version of the Governance ... organizations accomplish governance, risk and compliance (GRC) tasks across ... has also been updated to help customers better align ... Organizations of the Treadway Commission ) requirements. In response ...
(Date:2/26/2015)... Woodbridge, NJ (PRWEB) February 26, 2015 ... and its affiliated companies, Wilentz, Goldman & ... in a trade secrets lawsuit against Genewiz Inc. in ... illegally obtained and utilized GenScript’s trade secrets, and that ... The court entered an order denying motions for ...
Breaking Biology Technology:S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5SQI Diagnostics Reports First Quarter Financial Results 2SQI Diagnostics Reports First Quarter Financial Results 3SQI Diagnostics Reports First Quarter Financial Results 4SQI Diagnostics Reports First Quarter Financial Results 5SQI Diagnostics Reports First Quarter Financial Results 6Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 2Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 3Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3
Cached News: